AZITRA

🇲🇦Morocco
Ownership
-
Employees
-
Market Cap
$5.3M
Website
Clinical Trials
Related News

Evaluation of Topical ATR12-351 in Adults With Netherton Syndrome

Phase 1
Recruiting
Conditions
Netherton Syndrome
Interventions
Drug: ATR12-351
First Posted Date
2023-11-18
Last Posted Date
2024-06-21
Lead Sponsor
Azitra Inc.
Target Recruit Count
12
Registration Number
NCT06137157
Locations
🇺🇸

Yale University, New Haven, Connecticut, United States

Study to Evaluate the Safety of ATR-04

First Posted Date
2021-01-29
Last Posted Date
2021-06-07
Lead Sponsor
Azitra Inc.
Target Recruit Count
60
Registration Number
NCT04731259
Locations
🇺🇸

RCTS, Inc., Irving, Texas, United States

Safety Study of AZT-04 for Cosmetic Use

Not Applicable
Completed
Conditions
Study of Three Doses of AZT-04 for Skin Appearance
Interventions
Other: AZT-04
First Posted Date
2019-01-29
Last Posted Date
2020-07-09
Lead Sponsor
Azitra Inc.
Target Recruit Count
21
Registration Number
NCT03820076
Locations
🇺🇸

RCTS, Inc., Irving, Texas, United States

© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy